Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials.

医学 疾病 克罗恩病 临床试验 重症监护医学 鉴定(生物学) 梅德林 物理疗法
作者
Jeroen Geldof,Nusrat Iqbal,Jean-Frédéric LeBlanc,Sulak Anandabaskaran,Rachel Sawyer,Christianne Buskens,Willem Bemelman,Krisztina Gecse,Lilli Lundby,Amy L Lightner,Silvio Danese,Antonino Spinelli,Michele Carvello,Omar Faiz,Janindra Warusavitarne,Phillip Lung,Danny De Looze,André D'Hoore,Séverine Vermeire,Ailsa Hart,Phil Tozer
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier]
标识
DOI:10.1016/s2468-1253(22)00007-3
摘要

Perianal fistulising Crohn's disease is an aggressive disease phenotype that can have a substantial detrimental impact on patients' quality of life. Current biological understanding of perianal fistulising Crohn's disease remains inadequate and previous classification systems have not provided clear guidance on therapy in clinical practice nor on defining patient cohorts within clinical trials. We propose a new classification system for perianal fistulising Crohn's disease that was developed through a modified nominal group technique expert consensus process. The classification identifies four groups of patients. Key elements include stratification according to disease severity as well as disease outcome; synchronisation of patient and clinician goals in decision making, with a proactive, combined medical and surgical approach, on a treat to patient goal basis; and identification of indications for curative fistula treatment, diverting ostomy, and proctectomy. The new classification retains an element of flexibility, in which patients can cycle through different classes over time. Furthermore, with each specific class comes a paired treatment strategy suggestion and description of clinical trial suitability. The proposed classification system is the first of its kind and is an important step towards tailored standardisation of clinical practice and research in patients with perianal fistulising Crohn's disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
杰哥发布了新的文献求助30
刚刚
爱吃蛋挞的亮仔完成签到,获得积分10
2秒前
完美世界应助potato_bel采纳,获得10
3秒前
科目三应助Sarah采纳,获得10
4秒前
健忘的海莲完成签到,获得积分20
5秒前
斯文败类应助农大彭于晏采纳,获得10
5秒前
6秒前
9秒前
gogogo完成签到,获得积分10
9秒前
完美世界应助李可欣采纳,获得10
9秒前
刘娟发布了新的文献求助10
11秒前
牛牛发布了新的文献求助10
13秒前
Akim应助Singularity采纳,获得10
14秒前
dd发布了新的文献求助10
15秒前
无花果应助duyu采纳,获得10
15秒前
刘娟完成签到,获得积分10
19秒前
称心翠容发布了新的文献求助20
20秒前
琦琦完成签到 ,获得积分10
21秒前
懵懂的行恶完成签到,获得积分20
22秒前
25秒前
与123发布了新的文献求助10
25秒前
lily完成签到,获得积分20
26秒前
森sen完成签到 ,获得积分10
28秒前
支半雪发布了新的文献求助10
28秒前
32秒前
彩色觅露完成签到 ,获得积分10
32秒前
李爱国应助annoraz采纳,获得10
33秒前
35秒前
yu发布了新的文献求助10
37秒前
42秒前
zzz完成签到 ,获得积分10
42秒前
43秒前
dd完成签到,获得积分20
43秒前
lyylxcz完成签到,获得积分10
45秒前
47秒前
48秒前
50秒前
白开水完成签到,获得积分10
50秒前
51秒前
52秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
Pressing the Fight: Print, Propaganda, and the Cold War 500
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2471144
求助须知:如何正确求助?哪些是违规求助? 2137927
关于积分的说明 5447466
捐赠科研通 1861777
什么是DOI,文献DOI怎么找? 925939
版权声明 562740
科研通“疑难数据库(出版商)”最低求助积分说明 495278